Page 123 - Bradken Annual Report 2013_Page flip

Basic HTML Version

BRADKEN LIMITED ANNUAL REPORT 2013 87
Notes to the consolidated financial statements
30 June 2013
(continued)
35
Share based payments (continued)
The movements in Rights issues in the plan are as follows:
Grant Date
Fair value at
grant date
Balance at
start of the
year
Granted
during the
year
Exercised
during the
year
Expired
during the
year
Balance at
end of the
year
Exercisable at
end of the
year
Number
Number
Number
Number
Number
Number
2013
2.35
10,344
-
-
-
10,344
10,344
2.80
11,789
-
-
(4,449)
7,340
7,340
3.44
14,993
-
-
-
14,993
14,993
4.44
4,944
-
-
(1,591)
3,353
3,353
4.11
116
-
-
-
116
116
4.82
49,211
-
(36,521)
-
12,690
12,690
3.71
13,071
-
-
(13,071)
-
-
4.41
649,045
-
-
(649,045)
-
-
5.13
34,434
-
-
(10,446)
23,988
-
6.12
543,929
-
-
-
543,929
-
4.76
619,410
-
-
-
619,410
-
4.01
17,877
-
-
-
17,877
-
2.84
-
61,369
-
-
61,369
-
3.39
-
1,122,908
-
-
1,122,908
-
Total
1,969,163
1,184,277
(36,521)
(678,602)
2,438,317
48,836
Weighted average price
4.98
3.36
4.82
4.40
4.36
3.54
Vesting for the performance period to 30 June 2013 will occur following the test date on 13 August 2013.
2012
2.35
10,344
-
-
-
10,344
10,344
2.80
13,008
-
-
(1,219)
11,789
13,008
3.44
14,993
-
-
-
14,993
14,993
4.44
5,715
-
-
(771)
4,944
5,715
6.87
2,481
-
(2,481)
-
-
-
8.45
7,443
-
(7,443)
-
-
-
2.84
6,492
-
(2,580)
(3,912)
-
-
4.11
3,910
-
(1,032)
(2,762)
116
116
4.82
321,001
-
(135,025)
(136,765)
49,211
49,211
3.71
34,697
-
(20,507)
(1,119)
13,071
-
4.41
660,817
-
-
(11,772)
649,045
-
5.13
61,369
-
(26,935)
-
34,434
-
6.12
550,078
-
-
(6,149)
543,929
-
4.76
-
625,850
-
(6,440)
619,410
-
4.01
-
17,877
-
-
17,877
-
Total
1,692,348
643,727
(196,003)
(170,909)
1,969,163
93,387
Weighted average price
5.04
4.74
4.88
4.76
4.98
4.02
7 October 2011
7 October 2011
23 October 2012
23 October 2012
5 November 2010
29 October 2009
29 October 2009
31 October 2007
17 October 2008
17 October 2008
17 October 2008
30 October 2006
31 October 2007
31 October 2007
The expiry dates of all grants shown in the tables above are 10 years from the test date. The weighted average share price at the
date of exercise of Rights exercised regularly during the year ended 30 June 2013 was $6.17 (2012: $6.98). The weighted
average remaining contractual life of share Rights outstanding at the end of the period was 1.63 years (2012: 1.52 years).
18 November 2005
30 October 2006
30 October 2006
31 October 2007
17 October 2008
17 October 2008
29 October 2009
29 October 2009
5 November 2010
5 November 2010
7 October 2011
7 October 2011
5 November 2010
18 November 2005
30 October 2006
Page 87
Bradken Limited